Evidence of the role of short-term exposure to ozone on ischaemic cerebral and cardiac events: the Dijon Vascular Project (DIVA)

Henrotin, Jean-Bernard; Zeller, Marianne; Lorgis, Luc; Cottin, Yves; Giroud, Maurice; B⇔(c)jot, Yannick
December 2010
Heart;Dec2010, Vol. 96 Issue 24, p1990
Academic Journal
Objectives To confirm the effects of short-term exposure to ozone (O3) on ischaemic heart and cerebrovascular disease. Methods Daily levels of urban O3 pollution, the incidence of first-ever, recurrent, fatal and non-fatal ischaemic cerebrovascular events (ICVE) and myocardial infarction (MI) were correlated using a case-crossover design. The authors analysed 1574 ICVE and 913 MI that occurred in Dijon, France (150 000 inhabitants) from 2001 to 2007. Sulfur dioxide (SO2), nitrogen dioxide (NO2), carbon monoxide (CO) and particulate matter with an aerodiameter of =10⇔…⇔1/4g/m3 (PM10) were used to create bi-pollutant models. Using the adjusted OR, the effects of O3 exposure were calculated for every 10⇔…⇔1/4g/m3 increase in pollutants in multivariate logistic models adjusted for temperature, humidity, flu outbreaks and holidays. Results The authors found a significant association between exposure to O3 and recurrent ICVE with a 3-day lag (OR=1.115; 95% CI 1.027 to 1.209). The direction and magnitude of the association between exposure to O3 and recurrent MI were similar but not statistically significant. For incident events, the authors detected only a non-significant association for ICVE with a 2-day lag (OR=1.041; 95% CI 0.996 to 1.089). In the subgroup analysis for ICVE, the authors observed an increased association with cardiovascular risk factors (OR=1.523; 95% CI 1.149 to 2.018). For MI, the authors found an association with O3 when hypercholesterolaemia was present (OR=1.111; 95% CI 1.020 to 1.211), and the association became stronger with the number of cardiovascular risk factors. The authors found a marked dose-response relationship. Conclusion Recurrent ICVE and MI could be triggered by short-term exposure to even low levels of O3, especially among subjects with severe vascular risk factors.


Related Articles

  • DeCODE's Report on Cardiac Gene Study Causes a FLAP. Davies, Kevin // Bio-IT World;Mar2004, Vol. 3 Issue 3, p14 

    Reports on the concerns raised by scientific experts regarding a study published by deCODE Genetics linking discrete gene variations to increased risk of heart attack and stroke. Effect of the gene encoding 5-lipoxygenase activating protein (FLAP) on the risk of myocardial infarction and...

  • Biomarkers for coronary heart disease: predictive value or background noise? Mitka, Mike // JAMA: Journal of the American Medical Association;12/15/2004, Vol. 292 Issue 23, p2824 

    Looks at biomarkers for disease and how they may eventually aid in the diagnosis of illness. Attention on biomarker C-reactive protein which has been shown as a predictor of risk of myocardial infarction, stroke, sudden heart attack and peripheral arterial disease; Recommendations for when to...

  • Health talk.  // Pharmaceutical Executive;Oct97, Vol. 17 Issue 10, p112 

    Reports that Aetna Health Plans is committing $7 million through the Aetna Foundation and Aetna U.S. Healthcare to raise awareness among women about the risks of heart disease and stroke, the leading cause of death of women over the age of 25 in the United States.

  • Mortality from cardiovascular disease among interregional migrants in England and Wales. Strachan, D.P.; Leon, D.A. // BMJ: British Medical Journal (International Edition);2/18/95, Vol. 310 Issue 6977, p423 

    Investigates the extent to which geographical variations in mortality from ischemic heart disease and stroke in Great Britain are influenced by factors in early life or in adulthood. Genetic factors; Environmental exposures; Lifestyle.

  • Role of Lp(a) in coronary disease and stroke is controversial. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;03/25/98, Vol. 11 Issue 3, p28 

    Presents studies suggesting that lipoprotein (a) (Lp[a]) is a risk factor for coronary artery disease (CAD) and stroke. Differences in measurement methods; Possibility that Lp(a) may increase risk only in people with hypercholesterolemia; Reduction of elevated low-density lipoprotein...

  • Healthy coffee.  // New Scientist;10/20/90, Vol. 128 Issue 1739, p19 

    Reports on a study published in the October 11, 1990 issue of the 'New England Journal of Medicine,' which shows that four or more cups of coffee a day do not predispose a person to heart disease or strokes. Two-year study on male coffee drinkers; Contradiction of earlier investigations blaming...

  • Atrial fibrillation, ST elevation, and history predict post-MI stroke.  // Modern Medicine;Aug97, Vol. 65 Issue 8, p51 

    Presents an abstract of `Ischemic Stroke After Acute Mycocardial Infarction: A Population-Based Study,' by T. Mooe, P. Eriksson and B. Stegmayr from `Stroke' dated April 1997.

  • ABSTRACTS.  // JAMA: Journal of the American Medical Association;12/22/2004, Vol. 292 Issue 24, p2953 

    Presents abstracts held in the Journal of the American Medical Association archives. "Early Withdrawal of Statin Therapy in Patients With Non-ST-Segment Elevation Myocardial Infarction: National Registry of Myocardial Infarction," by Frederick Spencer et al.; "Prevalence of Heart Disease and...

  • Elevation of plasma homocysteine levels associated with acute myocardial infarction. Senaratne, Manohara P. J.; Griffiths, Jo; Nagendran, Jayan // Clinical & Investigative Medicine;Aug2000, Vol. 23 Issue 4, p220 

    Objective: To study the effect of acute myocardial infarction (AMI) on plasma homocystein (Hcy) levels, to determine the optimal time to measure this risk factor for coronary artery disease. Design: A prospective case study. Setting: The Division of Cardiac Sciences, Grey Nuns Hospital in...


Read the Article


Sign out of this library

Other Topics